N-acetylcysteine prevents electrical remodeling and attenuates cellular hypertro

Basic Research in Cardiology

Volumn 107, Issue 5, 2012, Pages

  Foltz, Wibke U ^a   Wagner, Michael ^a   Rudakova, Elena ^a   Volk, Tilmann ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Hypertrophy; N acetylcysteine; Oxidative stress; Pressure overload

Indexed keywords

ACETYLCYSTEINE; CALCIUM CHANNEL L TYPE; CALCIUM ION; POTASSIUM ION; ANTIOXIDANT; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; ASCENDING AORTA; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL CAPACITANCE; CALCIUM CURRENT; CELL SPECIFICITY; CONTROLLED STUDY; ENDOCARDIUM; EPICARDIUM; EXCISION; FEMALE; HEART ELECTROPHYSIOLOGY; HEART HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE WALL; HEART LEFT VENTRICLE WEIGHT; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE REMODELING; HEART WEIGHT; NONHUMAN; OXIDATIVE STRESS; PATCH CLAMP; RAT; SHAM PROCEDURE; SYSTOLIC BLOOD PRESSURE; WHOLE CELL; ACTION POTENTIAL; ANIMAL; AORTA; AORTA VALVE STENOSIS; CARDIOMEGALY; DRUG EFFECT; HEMODYNAMICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ACTION POTENTIALS; ANIMALS; ANTIOXIDANTS; AORTA; AORTIC VALVE STENOSIS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CARDIOMEGALY; ENDOCARDIUM; FEMALE; HEMODYNAMICS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR REMODELING;

EID: 84865045533     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0290-4     Document Type: Article

References (70)

1. Adamy C, Mulder P, Khouzami L, Andrieu-Abadie N, Defer N, Candiani G, Pavoine C, Caramelle P, Souktani R, Le CP, Perier M, Kirsch M, Damy T, Berdeaux A, Levade T, Thuillez C, Hittinger L, Pecker F (2007) Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in postmyocardial infarction failing heart rats. J Mol Cell Cardiol 43:344-353. doi:10.1016/j.yjmcc.2007.06.010
2. Armoundas AA, Wu R, Juang G, Marban E, Tomaselli GF (2001) Electrical and structural remodeling of the failing ventricle. Pharmacol Ther 92:213-230. doi:10.1016/S0163-7258(01)00171-1
3. 2+ current in adult rat cardiomyocytes. Circ Res 85:1139-1145. doi: 10.1161/01.RES.85.12.1139
4. 2+ current in ventricular cardiomyocytes. J Mol Cell Cardiol 48:26-36. doi: 10.1016/j.yjmcc.2009.07.026
5. Bourraindeloup M, Adamy C, Candiani G, Cailleret M, Bourin MC, Badoual T, Su JB, Adubeiro S, Roudot-Thoraval F, Dubois-Rande JL, Hittinger L, Pecker F (2004) N-acetylcysteine treatment normalizes serum tumor necrosis factor-a level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110:2003-2009. doi:10.1161/01.CIR.0000143630.14515.7C
6. Bryant SM, Shipsey SJ, Hart G (1999) Normal regional distribution of membrane current density in rat left ventricle is altered in catecholamine-induced hypertrophy. Cardiovasc Res 42:391-401. doi:10.1016/S0008-6363(99)00033-4
7. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, Shah AM (2003) Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93:802-805. doi:10.1161/01.RES. 0000099504.30207.F5
8. Cabassi A, Dumont EC, Girouard H, Bouchard JF, Le JM, Lamontagne D, Besner JG, de CJ (2001) Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 19:1233-1244
9. Chen X, Nakayama H, Zhang X, Ai X, Harris DM, Tang M, Zhang H, Szeto C, Stockbower K, Berretta RM, Eckhart AD, Koch WJ, Molkentin JD, Houser SR (2010) Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. J Mol Cell Cardiol. doi:10.1016/j.yjmcc. 2010.11.012
10. Costantini DL, Arruda EP, Agarwal P, Kim KH, Zhu Y, Zhu W, Lebel M, Cheng CW, Park CY, Pierce SA, Guerchicoff A, Pollevick GD, Chan TY, Kabir MG, Cheng SH, Husain M, Antzelevitch C, Srivastava D, Gross GJ, Hui CC, Backx PH, Bruneau BG (2005) The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123:347-358. doi:10.1016/j.cell.2005.08.004
11. Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, Hirotani S, Matsumura Y, Hori M, Tada M, Otsu K (2002) The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressureoverload model. J Am Coll Cardiol 39:907-912. doi: 10.1016/S0735-1097(01)01826-5
12. 2+ channels. J Physiol 545:399-406. doi:10.1113/jphysiol. 2002.021881
13. Eder P, Molkentin JD (2011) TRPC channels as effectors of cardiac hypertrophy. Circ Res 108:265-272. doi:10.1161/ CIRCRESAHA.110.225888
14. Erickson JR, He BJ, Grumbach IM, Anderson ME (2011) CaMKII in the cardiovascular system: Sensing redox states. Physiol Rev 91:889-915. doi:10.1152/physrev.00018.2010
15. Fernandez-Velasco M, Goren N, Benito G, Blanco-Rivero J, Bosca L, Delgado C (2003) Regional distribution of hyperpolarization-activated current If and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts. J Physiol 553:395-405. doi:10.1113/jphysiol.2003.041954
16. 2+ channels: One switch. J Physiol 554:275-283. doi: 10.1113/jphysiol.2003.047902
17. Furukawa T, Kurokawa J (2006) Potassium channel remodeling in cardiac hypertrophy. J Mol Cell Cardiol 41:753-761. doi: 10.1016/j.yjmcc.2006.07.021
18. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500-508. doi:10.1172/JCI24408
19. + current in spontaneously hypertensive rats. Cardiovasc Res 74:85-95. doi: 10.1016/j.cardiores.2007.01.001
20. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100. doi:10.1007/BF00656997
21. Henderson BC, Tyagi N, Ovechkin A, Kartha GK, Moshal KS, Tyagi SC (2007) Oxidative remodeling in pressure overload induced chronic heart failure. Eur J Heart Fail 9:450-457. doi: 10.1016/j.ejheart.2006.12.008
22. Hill JA (2003) Electrical remodeling in cardiac hypertrophy. Trends Cardiovasc Med 13:316-322. doi:10.1016/j.tcm.2003.08. 002
23. Hill MF, Singal PK (1996) Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148:291-300
24. Hool LC, Corry B (2007) Redox control of calcium channels: From mechanisms to therapeutic opportunities. Antioxid Redox Signal 9:409-435. doi:10.1089/ars.2006.1446
25. 2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal 1:e31. doi:10.1126/scisignal. 125pe31
26. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K, Arimura K, Egashira K, Takeshita A (1999) Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85:357-363. doi:10.1161/01.RES.85.4.357
27. Isenberg G, Klöckner U (1982) Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium". Pflugers Arch 395:6-18. doi:10.1007/BF00584963
28. Javadov S, Rajapurohitam V, Kilic A, Hunter JC, Zeidan A, Said FN, Escobales N, Karmazyn M (2011) Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: The effect of NHE-1 inhibition. Basic Res Cardiol 106:99-109. doi:10.1007/s00395-010-0122-3
29. Kääb S, Dixon J, Duc J, Ashen D, Näbauer M, Beuckelmann DJ, Steinbeck G, McKinnon D, Tomaselli GF (1998) Molecular basis of transient outward potassium current downregulation in human heart failure: A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98:1383-1393. doi: 10.1161/01.CIR.98.14.1383
30. Kahan T, Bergfeldt L (2005) Left ventricular hypertrophy in hypertension: Its arrhythmogenic potential. Heart 91:250-256. doi:10.1136/hrt.2004.042473
31. Keung EC (1989) Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circ Res 64:753-763. doi:10.1161/01.RES.64.4. 753
32. Kirchhof P, Fabritz L, Kilic A, Begrow F, Breithardt G, Kuhn M (2004) Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice. J Mol Cell Cardiol 36:691-700. doi: 10.1016/j.yjmcc.2004.03.007
33. Lapenna D, Mezzetti A, de GS, Consoli A, Festi D, Di IC, Cuccurullo F (1994) Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium. Pflugers Arch 427:432-436. doi:10.1007/BF00374257
34. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, Kaye DM, Ritchie RH (2006) Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 72:112-123. doi: 10.1016/j.cardiores.2006.07.006
35. Lebeche D, Kaprielian R, del Monte F, Tomaselli GF, Gwathmey JK, Schwartz A, Hajjar RJ (2004) In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 110:3435-3443. doi:10.1161/01.CIR.0000148176.33730.3F
36. Maejima Y, Kuroda J, Matsushima S, Ago T, Sadoshima J (2011) Regulation of myocardial growth and death by NADPH oxidase. J Mol Cell Cardiol 50:408-416. doi:10.1016/j.yjmcc.2010.12.018
37. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A (1998) Elevated levels of 8-iso-prostaglandin F2a in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97:1536-1539. doi:10.1161/01.CIR.97.16. 1536
38. Marian AJ, Senthil V, Chen SN, Lombardi R (2006) Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. J Am Coll Cardiol 47:827-834. doi:10.1016/j.jacc.2005. 10.041
39. McCrossan ZA, Billeter R, White E (2004) Transmural changes in size, contractile and electrical properties of SHR left ventricular myocytes during compensated hypertrophy. Cardiovasc Res 63:283-292. doi:10.1016/j.cardiores. 2004.04.013
40. Mozaffari MS, Baban B, Liu JY, Abebe W, Sullivan JC, El-Marakby A (2011) Mitochondrial complex I and NAD(P)H oxidase are major sources of exacerbated oxidative stress in pressure-overloaded ischemic-reperfused hearts. Basic Res Cardiol 106:287-297. doi:10.1007/s00395-011-0150-7
41. Murdoch CE, om-Ruiz SP, Wang M, Zhang M, Walker S, Yu B, Brewer A, Shah AM (2011) Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res Cardiol 106:527-538. doi:10.1007/ s00395-011-0150-7
42. Nakagami H, Takemoto M, Liao JK (2003) NADPH oxidasederived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 35:851-859. doi:10.1016/S0022-2828(03)00145-7
43. Perrier E, Kerfant BG, Lalevee N, Bideaux P, Rossier MF, Richard S, Gomez AM, Benitah JP (2004) Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation 110:776-783. doi:10.1161/01.CIR.0000138973.55605.38
44. + transient outward current via the calcineurin pathway. J Biol Chem 279:40634-40639. doi: 10.1074/jbc.M407470200
45. Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, Baliga R, Wang J, Siwik DA, Singh K, Pagano P, Colucci WS, Sawyer DB (2001) Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 89:453-460. doi:10.1161/hh1701.096615
46. Rossow CF, Dilly KW, Santana LF (2006) Differential calcineurin/ NFATc3 activity contributes to the Ito transmural gradient in the mouse heart. Circ Res 98:1306-1313. doi:10.1161/01.RES. 0000222028.92993.10
47. + channel remodeling in postinfarction rat heart. Am J Physiol Heart Circ Physiol 282:H2346-H2355. doi:10.1152/ajpheart.00894.2001
48. Sah R, Ramirez RJ, Kaprielian R, Backx PH (2001) Alterations in action potential profile enhance excitation-contraction coupling in rat cardiac myocytes. J Physiol 533:201-214
49. Sah R, Ramirez RJ, Oudit GY, Gidrewicz D, Trivieri MG, Zobel C, Backx PH (2003) Regulation of cardiac excitation-contraction coupling by action potential repolarization: Role of the transient outward potassium current (Ito). J Physiol 546:5-18. doi: 10.1113/jphysiol.2002.026468
50. Scamps F, Mayoux E, Charlemagne D, Vassort G (1990) Calcium current in single cells isolated from normal and hypertrophied rat heart. Effects of a-adrenergic stimulation. Circ Res 67:199-208. doi:10.1161/01.RES.67.1.199
51. Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93:903-907. doi:10.1136/hrt. 2005.068270
52. Seth M, Zhang ZS, Mao L, Graham V, Burch J, Stiber J, Tsiokas L, Winn M, Abramowitz J, Rockman HA, Birnbaumer L, Rosenberg P (2009) TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 105:1023-1030. doi:10.1161/CIR CRESAHA.109.206581
53. Sirker A, Zhang M, Shah AM (2011) NADPH oxidases in cardiovascular disease: Insights from in vivo models and clinical studies. Basic Res Cardiol 106:735-747. doi:10.1007/s00395-011-0190-z
54. Skryabin BV, Holtwick R, Fabritz L, Kruse MN, Veltrup I, Stypmann J, Kirchhof P, Sabrane K, Bubikat A, Voss M, Kuhn M (2004) Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by aMHC-Cremediated recombination. Genesis 39:288-298. doi:10.1002/gene. 20056
55. 2+ channel facilitation mediated by H2O2-induced activation of CaMKII in rat ventricular myocytes. J Mol Cell Cardiol 48:773-780. doi:10.1016/j.yjmcc.2009.10. 020
56. Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, Liu PP (2007) Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115:1398-1407. doi:10.1161/CIRCULATIONAHA.106.643585
57. + current. J Physiol 533:145-154. doi:10.1111/j.1469-7793.2001.0145b.x
58. Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Kruger M, Linke WA, Backs J, Regitz-Zagrosek V, Schafer K, Field LJ, Maier LS, Hasenfuss G (2010) Differential cardiac remodeling in preload versus afterload. Circulation 122:993-1003. doi:10.1161/CIRCULA TIONAHA.110.943431
59. Tsai CT, Wang DL, Chen WP, Hwang JJ, Hsieh CS, Hsu KL, Tseng CD, Lai LP, Tseng YZ, Chiang FT, Lin JL (2007) Angiotensin II increases expression of a1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ Res 100:1476-1485. doi:10.1161/01.RES. 0000268497.93085.e1
60. Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141:334-341. doi:10.1067/mhj.2001.113218
61. 2+ channel function in the absence of apoptosis in ventricular myocytes. Circ Res 100:1036-1044. doi:10.1161/01.RES.000026 3010.19273.48
62. 2+ current characteristics in endo-and epicardial myocytes from rat left ventricle with pressure-induced hypertrophy. Pflugers Arch 443:399-404. doi:10.1007/ s004240100712
63. + currents among the left ventricular wall of rats with ascending aortic stenosis. J Physiol 530:443-455. doi:10.1111/j.1469-7793.2001.0443k.x
64. 2+ influx in epicardial myocytes of the rat left ventricle. Exp Physiol 90:111-121. doi:10.1113/expphysiol.2004. 028712
65. + current and shorter action potential duration in Ga11 mutant mice. Pflugers Arch 459:607-618. doi:10.1007/s00424-009-0762-z
66. 2+ current in rat left ventricular cardiomyocytes. Acta Physiol (Oxf) 202:629-640. doi:10.1111/j.1748-1716.2011. 02303.x
67. 2+ current in pressure overload heart failure. J Biol Chem 283:25524-25532. doi: 10.1074/jbc.M803043200
68. Wickenden AD, Kaprielian R, Kassiri Z, Tsoporis JN, Tsushima R, Fishman GI, Backx PH (1998) The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res 37:312-323. doi: 10.1016/S0008-6363(97)00256-3
69. Xu L, Li XY, Liu Y, Li HT, Chen J, Li XY, Jiang XJ, Wu G, Tang YH, Wang X, Huang CX (2011) The mechanisms underlying ICa heterogeneity across murine left ventricle. Mol Cell Biochem 352:239-246. doi:10.1007/s11010-011-0759-8
70. Zafarullah M, Li WQ, Sylvester J, Ahmad M (2003) Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60:6-20. doi:10.1016/j.yjmcc.2010. 12.018